Skewed B cell differentiation affects lymphoid organogenesis but not T cell-mediated autoimmunity

Clinical and Experimental Immunology

Volumn 176, Issue 1, 2014, Pages 58-65

  Colombo, E ^a,b   Tentorio, P ^a,b   Musio, S ^b   Rajewsky, K ^d,e   Pedotti, R ^b   Casola, S ^c   Farina, C ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d CENTER FOR BLOOD RESEARCH   (United States)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

B cell receptor; B cells; EAE; LMP2A

Indexed keywords

LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

B CELL RECEPTOR; B CELLS; EAE; LMP2A;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; ORGANOGENESIS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, B-CELL; VIRAL MATRIX PROTEINS;

EID: 84895558361     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12250     Document Type: Article

References (22)

1. Tsantikos E, Maxwell MJ, Kountouri N, Harder KW, Tarlinton DM, Hibbs ML. Genetic interdependence of lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J Immunol 2012; 189:1726-1736.
2. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 1997; 7:133-143.
3. Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 1999; 11:495-506.
4. Jellusova J, Wellmann U, Amann K, Winkler TH, Nitschke L. CD22×Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol 2010; 184:3618-3627.
5. Samardzic T, Marinkovic D, Danzer CP, Gerlach J, Nitschke L, Wirth T. Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 2002; 32:561-567.
6. Rickert RC, Roes J, Rajewsky KB. Lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 1997; 25:1317-1318.
7. Wang JH, Avitahl N, Cariappa A etal. Aiolos regulates B cell activation and maturation to effector state. Immunity 1998; 9:543-553.
8. Casola S, Otipoby KL, Alimzhanov M etal. B cell receptor signal strength determines B cell fate. Nat Immunol 2004; 5:317-327.
9. Miller CL, Burkhardt AL, Lee JH etal. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995; 2:155-166.
10. Parra D, Rieger AM, Li J etal. Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells. J Leukoc Biol 2012; 91:525-536.
11. Gao J, Ma X, Gu W etal. Novel functions of murine B1 cells: active phagocytic and microbicidal abilities. Eur J Immunol 2012; 42:982-992.
12. Zhong X, Gao W, Degauque N etal. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur J Immunol 2007; 37:2400-2404.
13. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994; 93:2684-2690.
14. Lyons JA, Ramsbottom MJ, Trotter JL, Cross AH. Identification of the encephalitogenic epitopes of CNS proteolipid protein in BALB/c mice. J Autoimmun 2002; 19:195-201.
15. Menon R, Di Dario M, Cordiglieri C etal. Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 2012; 38:J144-155.
16. Colombo E, Cordiglieri C, Melli G etal. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J Exp Med 2012; 209:521-535.
17. Barr TA, Shen P, Brown S etal. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012; 209:1001-1010.
18. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-650.
19. Lampropoulou V, Hoehlig K, Roch T etal. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180:4763-4773.
20. Lyons JA, Ramsbottom MJ, Mikesell RJ, Cross AH. B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice. J Autoimmun 2008; 31:149-155.
21. Chang RA, Miller SD, Longnecker R. Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Sci Rep 2012; 2:353.
22. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003; 197:1073-1081.